Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 24.83B | 19.79B | 19.74B | 19.70B | 18.77B |
Gross Profit | 4.20B | 3.49B | 3.63B | 3.96B | 3.48B |
EBITDA | 1.72B | -189.00M | 959.00M | 1.42B | 1.01B |
Net Income | 749.00M | -873.00M | 524.00M | 1.06B | 968.00M |
Balance Sheet | |||||
Total Assets | 34.05B | 30.29B | 27.62B | 27.67B | 26.46B |
Cash, Cash Equivalents and Short-Term Investments | 2.92B | 3.90B | 4.43B | 5.55B | 4.62B |
Total Debt | 7.97B | 6.24B | 3.52B | 3.27B | 4.15B |
Total Liabilities | 15.31B | 12.96B | 10.27B | 10.78B | 10.35B |
Stockholders Equity | 18.74B | 17.33B | 17.35B | 16.89B | 16.11B |
Cash Flow | |||||
Free Cash Flow | -2.32B | -2.23B | -1.14B | 2.38B | -2.02B |
Operating Cash Flow | 55.00M | -1.07B | -506.00M | 3.05B | -1.27B |
Investing Cash Flow | -2.55B | -871.00M | -608.00M | -544.00M | -635.00M |
Financing Cash Flow | 1.49B | 2.48B | 22.00M | -1.61B | 1.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥13.65B | 10.73 | 2.00% | 2.63% | 268.28% | ||
80 Outperform | ¥17.41B | 9.93 | 2.05% | 20.91% | 18.64% | ||
77 Outperform | ¥19.43B | 13.92 | 1.72% | 22.80% | 39.62% | ||
71 Outperform | ¥13.16B | 10.42 | 3.56% | -6.96% | -1.72% | ||
61 Neutral | C$6.56B | 7.72 | 2.76% | 2.57% | 6.48% | -23.55% | |
57 Neutral | ¥12.46B | 16.16 | 1.99% | 25.48% | ― | ||
54 Neutral | ¥12.86B | ― | 5.58% | -6.30% | 34.61% |